Australia markets closed

BioHarvest Sciences Inc. (8MV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1540+0.0010 (+0.65%)
At close: 08:18AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-12,564
-12,564
-11,236
-9,827
-6,584
Depreciation & amortisation
840
840
712
389
288
Stock-based compensation
563
563
1,352
3,367
1,383
Change in working capital
755
755
-308
-96
-232
Accounts receivable
-262
-262
-159
-168
-180
Inventory
-1,088
-1,088
-450
-828
-49
Other working capital
-9,996
-9,996
-10,497
-8,434
-4,048
Other non-cash items
866
866
119
-1,265
1,357
Net cash provided by operating activities
-8,522
-8,522
-9,241
-6,794
-3,875
Cash flows from investing activities
Investments in property, plant and equipment
-1,474
-1,474
-1,256
-1,640
-173
Net cash used for investing activities
-1,474
-1,474
-1,256
-1,640
-173
Cash flows from financing activities
Debt repayment
-364
-364
-359
-332
-312
Common stock issued
-
-
0
7,466
4,469
Other financing activities
-
-
-38
-
-
Net cash used provided by (used for) financing activities
13,556
13,556
8,138
10,772
4,926
Net change in cash
3,560
3,560
-2,359
2,338
878
Cash at beginning of period
1,736
1,736
4,117
1,783
911
Cash at end of period
5,355
5,355
1,736
4,117
1,783
Free cash flow
Operating cash flow
-8,522
-8,522
-9,241
-6,794
-3,875
Capital expenditure
-1,474
-1,474
-1,256
-1,640
-173
Free cash flow
-9,996
-9,996
-10,497
-8,434
-4,048